Dennis Bourdette

发表

Selective depletion of myelin–reactive T cells with the anti–OX–40 antibody ameliorates autoimmune encephalomyelitis

D. Bourdette, E. Engleman, A. Weinberg, 1996, Nature Medicine.

Basic protein-specific T-cell lines that induce experimental autoimmune encephalomyelitis in SJL/J mice: comparison with Lewis rat lines.

D. Bourdette, C. Meshul, A. Vandenbark, 1988, Cellular immunology.

Genes * from Disease-Associated T Cell Receptor BV Complementarity-Determining Region 2 Peptides Sclerosis . III . Preferential Immunogenicity of Immunity to T Cell Receptor Peptides in Multiple

D. Bourdette, G. Nepom, A. Vandenbark, 1998 .

T cell receptor peptide therapy for autoimmune disease.

D. Bourdette, A. Vandenbark, H. Offner, 1992, Journal of autoimmunity.

Immunity to TCR peptides in multiple sclerosis. II. T cell recognition of V beta 5.2 and V beta 6.1 CDR2 peptides.

D. Bourdette, A. Weinberg, A. Vandenbark, 1994, Journal of immunology.

U.S. Gulf War Veterans: service periods in theater, differential exposures, and persistent unexplained illness. Portland Environmental Hazards Research Centre.

D. Bourdette, A. Barkhuizen, P. Spencer, 1998, Toxicology letters.

Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic V beta 5.2 and V beta 6.1 CDR2 peptides.

D. Bourdette, A. Vandenbark, H. Offner, 1994, Journal of immunology.

What Are the Risks of Guillain-Barré Syndrome After SARS-CoV-2 Infection and COVID-19 Vaccination?

E. Silbermann, Dennis Bourdette, 2023, Neurology.

BCG vaccine for clinically isolated syndrome and MS

Mary E. Jenkins, Amy J. Bastian, Jürgen Konczak, 2014, Neurology.

This information is current as Encephalomyelitis Relapses in Experimental Autoimmune Epitope Spreading Is Not Required for Vandenbark , Alex Zamora and Halina Offner

A. Vandenbark, Richard E. Jones, A. Zamora, 2003 .